×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Speakers
Rebecca Noel, DrPH, MPH
Executive Director, Benefit-Risk Assessment, Eli Lilly, United States
Rebecca (Becky) Noel is currently the Global Leader for Benefit-Risk Assessment at Eli Lilly. Since joining Lilly, Becky has been extensively involved in leading the development of systematic approaches to benefit-risk assessment, both internally at Lilly and externally via the PhRMA Benefit-Risk Action Team (BRAT), the Innovative Medicines Initiative PROTECT project, the International Conference on Harmonization, and via multiple other forums.
F. Reed Johnson, PhD, MA
Senior Research Scholar, Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University, United States
Brett Hauber, PhD, MA
Senior Director, Patient Preference Elicitation, Pfizer Inc, United States
Have an account?